TLR2 and head and neck squamous cell carcinoma: Given these observations with the HNSCC cell lines, we next assessed the expression of TLR2 in patient-derived xenografts (PDX), established from oral squamous cell carcinoma specimens obtained from patients undergoing surgical resection of their tumors.